LENSAR Inc (LNSR)
7.45
+0.17
(+2.34%)
USD |
NASDAQ |
Nov 21, 16:00
7.45
0.00 (0.00%)
After-Hours: 07:44
LENSAR Revenue (Quarterly): 13.54M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 13.54M |
| June 30, 2024 | 12.64M |
| March 31, 2024 | 10.59M |
| December 31, 2023 | 12.10M |
| September 30, 2023 | 9.795M |
| June 30, 2023 | 12.01M |
| March 31, 2023 | 8.252M |
| December 31, 2022 | 10.23M |
| September 30, 2022 | 7.748M |
| June 30, 2022 | 8.038M |
| March 31, 2022 | 9.34M |
| Date | Value |
|---|---|
| December 31, 2021 | 11.22M |
| September 30, 2021 | 8.272M |
| June 30, 2021 | 7.922M |
| March 31, 2021 | 7.043M |
| December 31, 2020 | 8.284M |
| September 30, 2020 | 7.145M |
| June 30, 2020 | 5.047M |
| March 31, 2020 | 5.906M |
| December 31, 2019 | 8.46M |
| September 30, 2019 | 8.068M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.047M
Minimum
Jun 2020
13.54M
Maximum
Sep 2024
9.179M
Average
8.372M
Median
Revenue (Quarterly) Benchmarks
| Standard BioTools Inc | 44.97M |
| Ainos Inc | -- |
| Zomedica Corp | 6.997M |
| Intelligent Bio Solutions Inc | 0.8723M |
| Adagio Medical Holdings Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.502M |
| Total Expenses (Quarterly) | 14.78M |
| EPS Diluted (Quarterly) | -0.13 |
| Enterprise Value | 68.45M |
| Gross Profit Margin (Quarterly) | 46.28% |
| Profit Margin (Quarterly) | -11.09% |
| Earnings Yield | -19.60% |
| Normalized Earnings Yield | -9.306 |